1. Home
  2. ZLAB vs ALE Comparison

ZLAB vs ALE Comparison

Compare ZLAB & ALE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • ALE
  • Stock Information
  • Founded
  • ZLAB 2013
  • ALE 1906
  • Country
  • ZLAB China
  • ALE United States
  • Employees
  • ZLAB N/A
  • ALE N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • ALE Power Generation
  • Sector
  • ZLAB Health Care
  • ALE Utilities
  • Exchange
  • ZLAB Nasdaq
  • ALE Nasdaq
  • Market Cap
  • ZLAB 3.2B
  • ALE 3.8B
  • IPO Year
  • ZLAB 2017
  • ALE N/A
  • Fundamental
  • Price
  • ZLAB $20.98
  • ALE $67.49
  • Analyst Decision
  • ZLAB Buy
  • ALE
  • Analyst Count
  • ZLAB 6
  • ALE 0
  • Target Price
  • ZLAB $57.22
  • ALE N/A
  • AVG Volume (30 Days)
  • ZLAB 899.6K
  • ALE 529.2K
  • Earning Date
  • ZLAB 11-06-2025
  • ALE 10-31-2025
  • Dividend Yield
  • ZLAB N/A
  • ALE 4.33%
  • EPS Growth
  • ZLAB N/A
  • ALE N/A
  • EPS
  • ZLAB N/A
  • ALE 2.85
  • Revenue
  • ZLAB $441,629,000.00
  • ALE $1,500,300,000.00
  • Revenue This Year
  • ZLAB $40.71
  • ALE $2.24
  • Revenue Next Year
  • ZLAB $50.42
  • ALE $5.63
  • P/E Ratio
  • ZLAB N/A
  • ALE $23.69
  • Revenue Growth
  • ZLAB 24.14
  • ALE N/A
  • 52 Week Low
  • ZLAB $20.61
  • ALE $62.38
  • 52 Week High
  • ZLAB $44.34
  • ALE $67.57
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 21.54
  • ALE 64.53
  • Support Level
  • ZLAB $21.59
  • ALE $67.35
  • Resistance Level
  • ZLAB $22.28
  • ALE $67.57
  • Average True Range (ATR)
  • ZLAB 0.86
  • ALE 0.13
  • MACD
  • ZLAB -0.18
  • ALE -0.06
  • Stochastic Oscillator
  • ZLAB 6.41
  • ALE 77.50

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About ALE Allete Inc.

ALLETE Inc provides competitively-priced energy in America's Upper Midwest region and invests in transmission infrastructure and other energy-centric businesses. The company has two reportable segments. The first segment is Regulated Operations, which includes the company's regulated utilities, Minnesota Power and SWL&P, as well as its investment in ATC. ATC is a regulated utility based in Wisconsin that owns and maintains electric transmission assets in parts of Wisconsin, Michigan, Minnesota, and Illinois. The second segment is ALLETE Clean Energy, which focuses on developing, acquiring, and operating clean and renewable energy projects.

Share on Social Networks: